These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31063266)

  • 1. IL-17A is not a treatment target in progressive vitiligo.
    Speeckaert R; Mylle S; van Geel N
    Pigment Cell Melanoma Res; 2019 Nov; 32(6):842-847. PubMed ID: 31063266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
    Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
    Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.
    Zhou L; Shi YL; Li K; Hamzavi I; Gao TW; Huggins RH; Lim HW; Mi QS
    Pigment Cell Melanoma Res; 2015 May; 28(3):324-9. PubMed ID: 25604047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
    Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
    Wu HQ; Zhao JJ; Li HW; Zhang Z
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
    [No Abstract]   [Full Text] [Related]  

  • 6. Th17 cells and activated dendritic cells are increased in vitiligo lesions.
    Wang CQ; Cruz-Inigo AE; Fuentes-Duculan J; Moussai D; Gulati N; Sullivan-Whalen M; Gilleaudeau P; Cohen JA; Krueger JG
    PLoS One; 2011 Apr; 6(4):e18907. PubMed ID: 21541348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
    Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
    Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
    Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
    Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Imbalance between Foxp3
    Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
    J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo.
    Vaccaro M; Cicero F; Mannucci C; Calapai G; Spatari G; Barbuzza O; Cannavò SP; Gangemi S
    Arch Dermatol Res; 2016 Sep; 308(7):527-30. PubMed ID: 27388717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients.
    Elela MA; Hegazy RA; Fawzy MM; Rashed LA; Rasheed H
    Eur J Dermatol; 2013; 23(3):350-5. PubMed ID: 23797460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype and function of circulating memory T cells in human vitiligo.
    Martins C; Darrigade AS; Jacquemin C; Barnetche T; Taieb A; Ezzedine K; Boniface K; Seneschal J
    Br J Dermatol; 2020 Nov; 183(5):899-908. PubMed ID: 32012221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant role of innate pro-inflammatory cytokines in vitiligo disease.
    Gholijani N; Yazdani MR; Dastgheib L
    Arch Dermatol Res; 2020 Mar; 312(2):123-131. PubMed ID: 31620869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
    Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
    Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.
    Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M
    BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated IL-17A secretion and CCR6 co-expression in Treg subsets are related to the imbalance of Treg/Th17 cells in active UC patients.
    Long Y; Zhao X; Xia C; Li X; Fan C; Liu C; Wang C
    Scand J Immunol; 2020 Jun; 91(6):e12842. PubMed ID: 31660620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
    Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
    Toussirot E
    Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1/17 cells.
    Zhang L; Kang Y; Chen S; Wang L; Jiang M; Xiang L
    J Dermatol Sci; 2019 Feb; 93(2):92-100. PubMed ID: 30655106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling.
    Bi L; Wu J; Ye A; Wu J; Yu K; Zhang S; Han Y
    J Transl Med; 2016 May; 14(1):132. PubMed ID: 27176825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.